Cytek Biosciences — Ransomware Incident Claimed by CMD
A biotechnology firm that develops and supplies advanced, cost-effective flow cytometry instruments and related services used worldwide by researchers and clinicians. Distinguished by offering high-end capabilities at lower cost, the company accelerates scientific discovery through technical innovation, exceptional customer support, and a commitment to ethical practices and community engagement. Headquartered in Fremont, California, it has been publicly traded on NASDAQ since 2021.